本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2019/6/41 分钟阅读
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of Five Abbreviated New Drug Applications for Pemoline Products
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing the approval of five abbreviated new drug applications (ANDAs) for products containing pemoline. The holders of the applications requested withdrawal of the applications and have waived their opportunity for a hearing.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →